Full CoverageTop news
Moderna Shares Jump With Positive Test Results for MRNA Flu Vaccine
By Robb M. Stewart
Moderna’s flu vaccine hits goal, paving way for combo shot
By Gerry Smith
Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot
By Annika Kim Constantino
All coverage
Immunogenicity and safety of mRNA-based seasonal influenza vaccines encoding hemagglutinin and neuraminidase
By Daniel Stadlbauer, Raffael Nachbagauer & Ivan T Lee
Pharmalittle: We're reading about a Moderna flu vaccine, a J&J loss over 340B rebate plans, and more
By Ed Silverman
Experimental Moderna flu shot more effective than approved vaccine, company says
By Alejandra O'connell-domenech
Moderna gets a win with new flu vaccine data
By Hannah Green
With new flu data, Moderna reconsiders its COVID combo
By Lee Landenberger
Trial of Moderna’s flu vaccine proves more effective than standard-dose shot in trial
By Hannah Green
Moderna says flu shot more effective than rival GSK in late-stage study
By Mariam E Sunny & Leroy Leo
Moderna's mRNA flu vaccine beats approved competitor in latest phase 3 win, teeing up push to FDA
By James Waldron
Moderna Stock Climbs on Trial Data. A Combined Flu-Covid Vaccine Is In Peril.
By Mackenzie Tatananni
Moderna's Phase 3 flu vaccine efficacy in line with competitors, teeing up new submissions
By Max Bayer
Moderna flu shot outperforms marketed vaccines in large late-stage trial
By Jonathan Gardner
Moderna's influenza vaccine superior to licensed shot in study
By Mariam E Sunny
Moderna’s Promised mRNA Flu Vaccine Bests Current Standard Shot
By Tristan Cesar Manalac
Moderna’s mRNA flu shot outperforms current standard at Phase III
By Abigail Beaney
Moderna's mRNA Flu Vaccine Outperforms Standard Shots
By Vandana Singh
Experimental Moderna flu shot more effective than approved vaccine, company says
By Alejandra O'connell-domenech